Accuray Stock Analysis (NASDAQ:ARAY)

Add to My Stocks
$4.8 $0.1 (2.13%) ARAY stock closing price Apr 26, 2017 (Closing)
Watch Robo Advisor Video of ARAY Stock Analysis
Accuray
Updated on : Apr 26, 2017
previous close
ARAY 4.8 (0%)
S&P 500 2387.5 (0%)
Closing Price On: Apr 26, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Instruments
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q2
$million
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
2.1%
Operating Profit
Operating Margin:
-2.4%
Sector Average:
0.6%
5 Quarter Net Profit
Net Margins
2017-Q2
%
LTM Margin
Debt/Equity Ratio
Debt:
206.6M
Debt/Equity Ratio:
 4.43
Compared to the industry
Cash Flow
Operating cash flow:
-$5M
Net Income:
-$9.4M
PROS      CONS
PS Valuation
Recent Growth
Long Term Growth
Operating Margins
Net Margins
High Debt Burden
ROIC
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
PE: N/A
ARAY PS :
1.1
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
-4.8%
Return on Equity:
-45.5%
Free Cash Flow Margin:
-7.9%
Double Tap To Exit Full Screen
0:00
/

Accuray Analysis Video

140 7 2

View Accuray stock analysis video. This is our ARAY analyst opinion covering the buy and sell arguments for ARAY stock.

Accuray Incorporated Stock Rating (1.9/5)

Our Accuray stock opinion is based on fundamentals of the company. This Accuray stock analysis is based on latest Q2 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy ARAY stock?

  • When compared with the Medical Instruments industry average PS ratio of 4.7, the price-to-sales ratio of 1.1 for ARAY stock is attractive.

Should you sell ARAY stock?

  • Accuray revenue saw a decline of -19.7% YoY in 2017 Q2.
  • Revenue growth of 2.1% has been weak over the last 5 years.
  • Over the last twelve months, Accuray posted an average operating loss margin of -2.4%.
  • Over the last 12 months, Accuray had an average Net loss of -6.9%.
  • Accuray has a debt/equity ratio of  4.43, which is worse than the average in the Medical sector.
  • PE ratio is meaningless for ARAY stock as the company has losses.
  • Accuray has a negative ROIC (Return on Invested Capital) of -4.8%.
  • Accuray has a negative return on equity of -45.5%. This indicates that the firm is inefficient at generating profits.
  • The company has a negative free cash flow margin of -7.9%.

Comments on this video and Accuray stock